Is a complete CSE/BNXT research report available?

Question

Accepted Answer

No complete published report is available for cse/BNXT (CSE/BNXT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap	46.3M
Net income (ttm)	-9.1M
EPS (ttm)	-CA$0.07
Shares out	136.1M
Volume	20,230
Beta	1.50

Metric	Value
Country	Canada
Country code	CA
Employees	20
Employees Change	19%
Employees Change Percent	1,900
Enterprise value	CAD 51.8M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE Fwd	21.97
Isin	CA0909741062
Last refreshed	2026-09-13
Market cap	CAD 46.3M
Price	CAD 0.34
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/BNXT
Website	https://www.bionxt.com

Metric	Value
Earnings Yield	-19.76%
FCF yield	-9.84%
P/B ratio	-7.4x

Metric	Value
Net Income	CAD -9.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
ROA	-387.5
Roa5y	-280.5
ROCE	130.6

Metric	Value
Cagr1y	-62.66%
Cagr3y	-0.96%
Cagr5y	-27.18%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

CSE/BNXT (CSE/BNXT)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/BNXT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/BNXT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/BNXT

Frequently asked questions

Metric	Value
Assets	CAD 1.5M
Cash	CAD 1.2M
Current Assets	CAD 1.3M
Current Liabilities	CAD 6.7M
Debt	CAD 6.7M
Debt FCF	CAD -1.47
Equity	CAD -6.3M
Interest Coverage	-4.31
Liabilities	CAD 7.8M
Long Term Assets	CAD 258,350
Long Term Liabilities	CAD 1.1M
Net Cash	CAD -5.5M
Net Cash By Market Cap	CAD -11.85
Tangible Book Value	CAD -6.3M
Tangible Book Value Per Share	CAD -0.05
WACC	13.24

Metric	Value
Current ratio	0.19
Net Working Capital	CAD -1M
Quick ratio	0.19
Working Capital	CAD -5.4M

Metric	Value
1Y total return	-62.64%
200-day SMA	0.52
3Y total return	-2.86%
50-day SMA	0.34
50-day SMA vs 200-day SMA	50under200
5Y total return	-79.52%
All Time High	3.55
All Time High Change	-90.42%
All Time High Date	2020-04-22
All Time Low	0.17
All Time Low Change	100%
All Time Low Date	2024-06-21
ATR	0.02
Beta	1.5
Beta1y	-0.94
Beta2y	0.04
Ch YTD	-46.88
High	0.35
High52	0.95
High52 Date	2025-09-11
High52ch	-64.21%
Low	0.34
Low52	0.28
Low52 Date	2026-07-21
Low52ch	21.43%
Ma50ch	0.68%
Price vs 200-day SMA	-34.78%
RSI	50.48
RSI Monthly	40.95
RSI Weekly	33.29
Sharpe ratio	-0.59x
Sharpe Ratio3y	0.27x
Sharpe Ratio5y	0.02x
Sortino ratio	-0.8
Sortino Ratio3y	0.48
Sortino Ratio5y	0.09
Total Return	-8.39%
Tr YTD	-46.88
Tr1m	4.62%
Tr1w	-5.56%
Tr3m	-12.82%

Metric	Value
Float	128,566,452%
Net Borrowing	1,250,400
Shares Insiders	5.53%
Shares Out	136,093,152
Shares Qo Q	3.76%
Shares Yo Y	8.39%

Metric	Value
Adjusted FCF	CAD -7.5M
Adjusted OCF	-7,479,676
Average Volume	46,518.45x
Bv Per Share	-0.05
Ch1m	4.62
Ch1w	-5.56
Ch1y	-62.64
Ch3m	-12.82
Ch3y	-2.86
Ch5y	-79.52
Ch6m	-45.16
Change	3.03%
Change From Open	-2.86
Close	0.33
Days Gap	6.06
Depreciation Amortization	11,827
Dollar Volume	6,878.2
Earnings Date	2026-11-27
EBIT	CAD -6.7M
EBITDA	CAD -6.7M
EPS	CAD -0.07
F Score	3
FCF	CAD -4.6M
FCF EV Yield	-8.8x
FCF Per Share	CAD -0.03
Financing CF	5,658,418
Fiscal Year End	December
Founded	2,017
Income Tax	CAD -197,469
Investing CF	92,259
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2026-06-30
Ma150	0.46
Ma150ch	-26.28%
Ma20	0.34
Ma20ch	0.89%
Net CF	1,198,114
Next Earnings Date	2026-11-27
Open	0.35
Position In Range	0
Ppne	208,348
Price Date	2026-09-11
Relative Volume	0.44x
Share Based Comp	2,925,892
Tr6m	-45.16%
Volume	20,230